Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC39H39ClN8O6S |
InChIKeyKVKRYCAWRGWYNN-MBMZGMDYSA-N |
CAS Registry1957234-97-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 12 Jan 2017 |